Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamicle, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study

Authors

M. S. Cairo
V. Davenport
O. Bessmertny
S. C. Goldman
S. L. Berg

Document Type

Journal Article

Publication Date

2005

Journal

British Journal of Haematology

Volume

128

Issue

1

Inclusive Pages

49-58

APA Citation

Cairo, M., Davenport, V., Bessmertny, O., Goldman, S., & Berg, S. (2005). Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamicle, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study. British Journal of Haematology, 128 (1). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/4257